How the EMA has calculated that the benefits of vaccinating with Astrazaneca far outweigh the risks by age group

No treatment or vaccine is risk-free. So the key question is whether it does more good than bad. Regarding the AstraZeneca vaccineBoth the MHRA and EMA reviews reaffirm that the benefits continue to far outweigh the risks.

However, the risks are not the same for all age groups, so the cost-benefit calculation varies (although in all cases it is always favorably inclined towards profits).

Read more

Apple considered launching iMessage for Android but did not do so to prevent users from switching to Android

On the occasion of Epic’s lawsuit against Apple for the withdrawal of Fortnite from the App Store for violating the rules of the store, we have just confirmed what in a way it could already be intuited for years: that Apple doesn’t release iMessage for Android to keep users tied to its ecosystem.

Apple’s iMessage is an application of hypervitamin SMS messaging, similar to what Google is doing with RCS chat functions. Although it is possible to use iMessage with Android users, they receive normal SMS.

Read more